Cooper Companies (NASDAQ:COO) Stock Price Crosses Above 200-Day Moving Average of $91.34

The Cooper Companies, Inc. (NASDAQ:COO)’s share price passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $91.34 and traded as high as $92.12. Cooper Companies shares last traded at $90.20, with a volume of 1,004,335 shares changing hands.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on COO shares. Mizuho increased their target price on shares of Cooper Companies from $102.50 to $115.00 and gave the company a “buy” rating in a report on Friday, March 1st. JPMorgan Chase & Co. upgraded shares of Cooper Companies from a “neutral” rating to an “overweight” rating and increased their price target for the company from $100.00 to $120.00 in a research report on Wednesday, March 13th. Piper Sandler increased their price target on shares of Cooper Companies from $110.00 to $115.00 and gave the company an “overweight” rating in a research report on Friday, March 1st. Citigroup increased their price target on shares of Cooper Companies from $108.00 to $116.00 and gave the company a “buy” rating in a research report on Wednesday, April 3rd. Finally, Stifel Nicolaus reiterated a “buy” rating and issued a $110.00 price target (up from $105.00) on shares of Cooper Companies in a research report on Friday, March 1st. Three equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $109.48.

Cooper Companies Stock Performance

The company has a market cap of $17.93 billion, a price-to-earnings ratio of 61.68, a price-to-earnings-growth ratio of 2.28 and a beta of 0.94. The stock’s fifty day simple moving average is $97.59 and its two-hundred day simple moving average is $91.34. The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.08 and a current ratio of 1.86.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings results on Thursday, February 29th. The medical device company reported $0.85 earnings per share for the quarter, beating analysts’ consensus estimates of $0.78 by $0.07. The company had revenue of $931.60 million for the quarter, compared to analyst estimates of $915.93 million. Cooper Companies had a net margin of 7.93% and a return on equity of 8.79%. Cooper Companies’s revenue for the quarter was up 8.5% on a year-over-year basis. During the same quarter last year, the business earned $2.90 EPS. Equities research analysts anticipate that The Cooper Companies, Inc. will post 3.5 EPS for the current year.

Insider Buying and Selling at Cooper Companies

In other Cooper Companies news, Director Gary S. Petersmeyer sold 1,000 shares of Cooper Companies stock in a transaction on Tuesday, March 5th. The shares were sold at an average price of $103.51, for a total value of $103,510.00. Following the transaction, the director now owns 5,668 shares in the company, valued at approximately $586,694.68. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In other news, CAO Agostino Ricupati sold 54,724 shares of the firm’s stock in a transaction on Monday, March 18th. The shares were sold at an average price of $100.89, for a total value of $5,521,104.36. Following the transaction, the chief accounting officer now owns 5,081 shares of the company’s stock, valued at approximately $512,622.09. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Gary S. Petersmeyer sold 1,000 shares of the firm’s stock in a transaction on Tuesday, March 5th. The shares were sold at an average price of $103.51, for a total transaction of $103,510.00. Following the completion of the transaction, the director now directly owns 5,668 shares in the company, valued at approximately $586,694.68. The disclosure for this sale can be found here. 2.00% of the stock is owned by company insiders.

Institutional Investors Weigh In On Cooper Companies

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Cary Street Partners Investment Advisory LLC purchased a new stake in Cooper Companies during the 3rd quarter worth $26,000. Blue Trust Inc. increased its stake in Cooper Companies by 54.8% during the 4th quarter. Blue Trust Inc. now owns 96 shares of the medical device company’s stock worth $36,000 after buying an additional 34 shares during the period. Lindbrook Capital LLC increased its stake in Cooper Companies by 182.5% during the 4th quarter. Lindbrook Capital LLC now owns 113 shares of the medical device company’s stock worth $43,000 after buying an additional 73 shares during the period. Venturi Wealth Management LLC increased its stake in Cooper Companies by 60.5% during the 3rd quarter. Venturi Wealth Management LLC now owns 138 shares of the medical device company’s stock worth $44,000 after buying an additional 52 shares during the period. Finally, Desjardins Global Asset Management Inc. increased its stake in Cooper Companies by 44.8% during the 4th quarter. Desjardins Global Asset Management Inc. now owns 152 shares of the medical device company’s stock worth $58,000 after buying an additional 47 shares during the period. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.